A leading biopharmaceutical company has revealed that they will invest €145m in their Dublin plant and with it create up to 400 jobs.

Pfizer will make the investment at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co. Dublin.

The investment will enable Pfizer to introduce two new processing suites to the site and expand current production and product testing capabilities.

Meanwhile the project will result in the generation of significant construction employment (up to 400 jobs) during peak construction periods.

-- Advertisement --

Pfizer is one of Ireland’s leading employers and the largest pharmaceutical investor. As one of the first pharmaceutical companies to locate in Ireland the company employs 4,300 people across eight locations based in Cork, Dublin, Kildare and Limerick.

Pfizer’s Grange Castle facility is one of the largest biotech manufacturing sites in the world and currently produces two of the company’s blockbuster medicines – Enbrel and Prevenar 13.

Grange Castle is strategically important to the company globally. Since opening in 2005, it has evolved into a highly specialised site for manufacturing, testing and developing medicines for patients around the world.

Making today's announcement, Taoiseach Enda Kenny said: "Pfizer has made a tremendous contribution to Ireland’s Life Sciences industry since it first established here in 1969 and this investment is a further demonstration of the company’s continuous commitment to Ireland."

The site currently employs approximately 1100 full time staff.

(LB/GK)